Skip to main content

Advertisement

Table 3 Incidence of new-onset diabetes and clinical events during the 3-year follow-up

From: Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up

VariablePitavastatin 1 mg (n = 251)Pitavastatin 4 mg (n = 251)p-value
New-onset diabetes14 (5.6%)9 (3.6%)0.39
 Baseline ~ 1 year1 (0.4%)0 (0.0%)0.99
 > 1 year13 (5.2%)9 (3.6%)0.39
All cause death9 (3.6%)8 (3.2%)0.99
Cardiac death3 (1.2%)1 (0.4%)0.62
Non-fatal myocardial infarction14 (5.6%)8 (3.2%)0.28
Ischemic stroke5 (2.0%)2 (0.8%)0.45
Target lesion revascularization12 (4.8%)9 (3.6%)0.66
Target vessel revascularization18 (7.2%)13 (5.2%)0.46
Non-target lesion/vessel revascularization7 (2.8%)15 (6.0%)0.13
  1. Values are presented as n (%)